Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2032

Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2032



The global oxytocin market size is expected to reach USD 193.02 million by 2032, according to a new study by Polaris Market Research. The report “Oxytocin Market Share, Size, Trends, Industry Analysis Report, By Indication (Antepartum, Postpartum), By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is experiencing growth driven by increasing initiatives in maternal healthcare, which prioritize safe and effective obstetric care. Oxytocin, essential for labor induction and managing postpartum haemorrhage, plays a pivotal role in maternal healthcare. Efforts to decrease maternal mortality rates, enhance access to quality healthcare, and improve obstetric practices contribute to the rising demand for oxytocin injections. Additionally, endeavors to ensure the availability of essential medicines in maternal health programs are propelling the market, underscoring oxytocin's crucial role in enhancing maternal outcomes and overall obstetric care, particularly in regions facing significant maternal healthcare challenges.

The increasing prevalence of cesarean section deliveries is propelling the market, as oxytocin plays a critical role in enhancing or initiating labor during scheduled and emergency cesarean sections. With a growing number of cesarean deliveries worldwide, the need for oxytocin injections for labor enhancement or post-surgery uterine contraction is escalating. Oxytocin is vital for preventing postpartum haemorrhage and facilitating safe deliveries during cesarean sections.

Oxytocin serves as a crucial intervention in preventing & managing PPH, a primary cause of mortality. Awareness among the healthcare providers & policymakers regarding the life-saving impact of the oxytocin injections in controlling the excessive bleeding. Maternal health programs, campaigns, & health initiatives that emphasize the importance of PPH prevention further stimulate the adoption of oxytocin injections. Healthcare systems helps in reducing the mortality rates, owing to the oxytocin role in preventing the PPH.

Oxytocin Market Report Highlights
  • Postpartum segment garnered the largest share, owing to rise in maternal mortalities and concerned complications
  • Hospital segment dominated the market, as they are fully equipped with all medical facilities
  • APAC will grow at the fastest rate, owing to rise in child births and awareness regarding maternal health
  • The key market players include Pfizer, Novartis, Ferring, Fresenius Kabi, Hikma Pharmaceuticals, Endo International, Sun Pharmaceutical and Yuhan Corporation
Polaris Market Research has segmented the oxytocin market report based on indication, distribution channel, and region:

Oxytocin, Indication Outlook (Revenue - USD Million, 2019 - 2032)
  • Antepartum
  • Postpartum
Oxytocin, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
Oxytocin, Regional Outlook (Revenue - USD Million, 2019 - 2032)
  • North America
- U.S.

- Canada
  • Europe
- Germany

- UK

- France

- Italy

- Spain

- Russia

- Netherlands

- Rest of Europe
  • Asia Pacific
- China

- India

- Japan

- South Korea

- Indonesia

- Malaysia

- Australia

- Rest of APAC
  • Latin America
- Argentina

- Brazil

- Mexico

- Rest of Latin America
  • Middle East & Africa
- UAE

- Saudi Arabia

- Israel

- South Africa

- Rest of MEA


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Oxytocin Market Insights
4.1. Oxytocin Market – Industry Snapshot
4.2. Oxytocin Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rise in abortion and unwanted pregnancies
4.2.1.2. Rise in cesarean deliveries
4.2.2. Restraints and Challenges
4.2.2.1. Stringent regulations impacting market access and growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Oxytocin Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Oxytocin Market, by Indication
5.1. Key Findings
5.2. Introduction
5.2.1. Global Oxytocin, by Indication, 2019-2032 (USD Million)
5.3. Antepartum
5.3.1. Global Oxytocin Market, by Antepartum, by Region, 2019-2032 (USD Million)
5.4. Postpartum
5.4.1. Global Oxytocin Market, by Postpartum, by Region, 2019-2032 (USD Million)
6. Global Oxytocin Market, by Distribution Channel
6.1. Key Findings
6.2. Introduction
6.2.1. Global Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
6.3. Hospital Pharmacies
6.3.1. Global Oxytocin Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)
6.4. Drug Stores
6.4.1. Global Oxytocin Market, by Drug Stores, by Region, 2019-2032 (USD Million)
6.5. Online Pharmacies
6.5.1. Global Oxytocin Market, by Online Pharmacies, by Region, 2019-2032 (USD Million)
7. Global Oxytocin Market, by Geography
7.1. Key findings
7.2. Introduction
7.2.1. Oxytocin Market Assessment, By Geography, 2019-2032 (USD Million)
7.3. Oxytocin Market – North America
7.3.1. North America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.3.2. North America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.3.3. Oxytocin Market – U.S.
7.3.3.1. U.S.: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.3.3.2. U.S.: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.3.4. Oxytocin Market – Canada
7.3.4.1. Canada: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.3.4.2. Canada: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4. Oxytocin Market – Europe
7.4.1. Europe: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.2. Europe: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4.3. Oxytocin Market – UK
7.4.3.1. UK: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.3.2. UK: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4.4. Oxytocin Market – France
7.4.4.1. France: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.4.2. France: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4.5. Oxytocin Market – Germany
7.4.5.1. Germany: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.5.2. Germany: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4.6. Oxytocin Market – Italy
7.4.6.1. Italy: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.6.2. Italy: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4.7. Oxytocin Market – Spain
7.4.7.1. Spain: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.7.2. Spain: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4.8. Oxytocin Market – Netherlands
7.4.8.1. Netherlands: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.8.2. Netherlands: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.4.9. Oxytocin Market – Russia
7.4.9.1. Russia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.4.9.2. Russia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5. Oxytocin Market – Asia Pacific
7.5.1. Asia Pacific: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.5.2. Asia Pacific: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5.3. Oxytocin Market – China
7.5.3.1. China: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.5.3.2. China: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5.4. Oxytocin Market – India
7.5.4.1. India: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.5.4.2. India: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5.5. Oxytocin Market – Malaysia
7.5.5.1. Malaysia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.5.5.2. Malaysia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5.6. Oxytocin Market – Japan
7.5.6.1. Japan: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.5.6.2. Japan: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5.7. Oxytocin Market – Indonesia
7.5.7.1. Indonesia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.5.7.2. Indonesia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.5.8. Oxytocin Market – South Korea
7.5.8.1. South Korea: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.5.8.2. South Korea: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.6. Oxytocin Market – Middle East & Africa
7.6.1. Middle East & Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.6.2. Middle East & Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.6.3. Oxytocin Market – Saudi Arabia
7.6.3.1. Saudi Arabia: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.6.3.2. Saudi Arabia: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.6.4. Oxytocin Market – UAE
7.6.4.1. UAE: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.6.4.2. UAE: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.6.5. Oxytocin Market – Israel
7.6.5.1. Israel: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.6.5.2. Israel: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.6.6. Oxytocin Market – South Africa
7.6.6.1. South Africa: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.6.6.2. South Africa: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.7. Oxytocin Market – Latin America
7.7.1. Latin America: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.7.2. Latin America: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.7.3. Oxytocin Market – Mexico
7.7.3.1. Mexico: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.7.3.2. Mexico: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.7.4. Oxytocin Market – Brazil
7.7.4.1. Brazil: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.7.4.2. Brazil: Oxytocin Market, by Indication, 2019-2032 (USD Million)
7.7.5. Oxytocin Market – Argentina
7.7.5.1. Argentina: Oxytocin Market, by Distribution Channel, 2019-2032 (USD Million)
7.7.5.2. Argentina: Oxytocin Market, by Indication, 2019-2032 (USD Million)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Pfizer Inc
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. Novartis AG
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Ferring B.V
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Fresenius Kabi LLC
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. Hikma Pharmaceuticals PLC
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Endo International plc. (Par Sterile Products, LLC)
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Teva Pharmaceutical Industries Ltd.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. Mylan N.V.
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. Wockhardt Ltd.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Sun Pharmaceutical Industries Ltd
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. Yuhan Corporation
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings